Clinical & Molecular Epidemiology Shared Resource

2003

Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD. Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples.
Pharmacogenetics. Aug; 13(8):501-7, 2003.

2005

Schwartz JL, Baker V, Larios E, Chung FL: Molecular and cellular effects of green tea on oral cells of smokers: a pilot study. Mol Nutr Food Res 2005; 49(1):43-51

Nada O, bdel-Hamid M, Ismail A, El SL, Sidhom KF, El Badawy NM, Ghazal FA, El DM, El KS, Esmat G, Loffredo CA: The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma. J Clin Virol 2005; 34(2):140-146.

El-Kafrawy SA, bdel-Hamid M, El-Daly M, Nada O, Ismail A, Ezzat S, bdel-Latif S, bdel-Hamid A, Shields PG, Loffredo C: P53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health 2005; 208(4):263-270.

Ressom HW, Varghese RS, bdel-Hamid M, Eissa SA, Saha D, Goldman L, Petricoin EF, Conrads TP, Veenstra TD, Loffredo CA, Goldman R: Analysis of mass spectral serum profiles for biomarker selection. Bioinformatics 2005; 21(21):4039-4045.

2006

DeMarco TA, Loffredo CA, Sampilo ML, Tercyak KP: On using a cancer center cancer registry to identify newly affected women eligible for hereditary breast cancer syndrome testing: practical considerations. J Genet Couns 2006; 15(2):129-136.

Orvisky E, Drake SK, Martin BM, Abdel-Hamid M, Ressom HW, Varghese RS, An Y, Saha D, Hortin GL, Loffredo CA, Goldman R: Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 2006; 6(9):2895-2902.

Ressom HW, Varghese RS, Orvisky E, Drake SK, Hortin GL, Abdel-Hamid M, Loffredo CA, Goldman R: Ant colony optimization for biomarker identification from maldi-tof mass spectra. Conf Proc IEEE Eng Med Biol Soc 2006; 1:4560-4563.

2007

Tercyak KP, Davis KM, Loffredo CA. Behavioral risk factors among Black and White women newly diagnosed with breast cancer. Psycho-Oncology 2007;16: 224-31.

Goldman R, Ressom HW, bdel-Hamid M, Goldman L, Wang A, Varghese RS, An Y, Loffredo CA, Drake SK, Eissa SA, Gouda I, Ezzat S, Moiseiwitsch FS: Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum. Carcinogenesis 2007; 28(10):2149-2153.

Radwan GN, Setouhy ME, Mohamed MK, Hamid MA, Israel E, Azem SA, Kamel O, Loffredo CA: DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers. Nicotine Tob Res 2007; 9(12):1325-1329.

Ressom HW, Varghese RS, Drake SK, Hortin GL, Abdel-Hamid M, Loffredo CA, Goldman R: Peak selection from MALDI-TOF mass spectra using ant colony optimization. Bioinformatics 2007; 23(5):619-626.

2008

Saha DT, Davidson BJ, Wang A, Pollock AJ, Orden RA, Goldman R: Quantification of DNA repair capacity in whole blood of patients with head and neck cancer and healthy donors by comet assay. Mutat Res 2008; 650(1):55-62.

Isailovic D, Kurulugama RT, Plasencia MD, Stokes ST, Kyselova Z, Goldman R, Mechref Y, Novotny MV, Clemmer DE: Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J Proteome Res 2008; 7(3):1109-1117.

Ressom HW, Varghese RS, Goldman L, Loffredo CA, Abdel-Hamid M, Kyselova Z, Mechref Y, Novotny M, Goldman R: Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers. Pac Symp Biocomput 2008;216-227.

Ressom HW, Varghese RS, Goldman L, An Y, Loffredo CA, Abdel-Hamid M, Kyselova Z, Mechref Y, Novotny M, Drake SK, Goldman R: Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res 2008; 7(2):603-610.

Tan D, Goerlitz DS, Dumitrescu RG, Han D, Seillier-Moiseiwitsch F, Spernak SM, Orden RA, Chen J, Goldman R, Shields PG: Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis 2008; 29(6):1170-1177.